IN RE OMEPRAZOLE PATENT LITIGATION

No. M-21-81 (BSJ), MDL Docket No. 1291, Nos. 00 Civ. 6749(BSJ), 03 Civ. 6057(BSJ), 00 Civ. 4541(BSJ), 03 Civ. 8719(BSJ), 01 Civ. 9351(BSJ), 00 Civ. 7597(BSJ), 01 Civ. 2998(BSJ).

490 F.Supp.2d 381 (2007)

In re OMEPRAZOLE PATENT LITIGATION. Astrazeneca AB, et al., Plaintiffs, v. Mylan Laboratories Inc., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Laboratorios Dr. Esteve, S.A., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Lek Pharmaceutical and Chemical Co., D.D., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Apotex Corp., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Impax Laboratories, Inc., Defendant.

United States District Court, S.D. New York.

May 31, 2007.


Attorney(s) appearing for the Case

Errol B. Taylor, Fred Zullow, Jack Griem, Milbank, Tweed, Hadley & McCloy for Astrazaneca.

Robert S. Silver, Allan H. Fried, William C. Youngblood, Marc Bassler, Alan H. Bernstein, Lynne Terrebonne, Ceasar, Rivise, Bernstein, Cohen & Pokotilow, Karen J. Bernstein, Pryor, Cahsman, Sherman & Flynn, LLP, for Apotex.

Jeffrey J. Toney, John North, Sutherland, Asbill & Brennan, LLP, Steven J. Lee, Thomas J. Meloro, Anthony Giaccio, Kenyon & Kenyon, for Impax.

Douglass C. Hochstetler, Beth D. Jacob, Joanne Kokoski, Schiff, Hardin & Waite, Michael Muczynski, Marshall Gerstein & Borum, Joseph Angland, Heller Ehrmann LLP, for Lek.

Mark A. Pacella, James H. Wallace, Jr., Wiley, Rein & Fielding, for Mylan & Esteve.


Opinion & Order

BARBARA S. JONES, United States District Judge.

TABLE OF CONTENTS

INTRODUCTION ............................................................................390

   I.  The Parties ......................................................................390

  II.  The Patents-In-Suit .......................................

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases